Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Research offers new hope for antibiotic resistance
Scientists say their findings could reverse the rising tide of antibiotic resistance.
Findings could ‘turn back the rising tide' of AMR

What makes some bacteria resistant to the most commonly prescribed antibiotics, and how this can be reversed, has been identified by scientists.

In a study, a team of researchers defined the relative importance of two mechanisms associated with β-lactams - a commonly prescribed group of antibiotics that includes penicillins, cephalosporins and carbapenems.

They found that, in one mechanism, bacteria restrict the entry of antibiotics into the cell. In the other, bacteria produce an enzyme, which destroys any antibiotic that gets into the cell. The latter was identified as the as the more important of the two mechanisms.

Scientists say their findings suggest that if chemicals could be developed to inhibit β-lactamase enzymes, a significant proportion of antibiotic resistance could be successfully reversed.

Building on these findings, a team from the University of Bristol studied the effectiveness of two types of β-lactamase enzyme inhibitor in a bacterium known to be highly resistant to common antibiotics.

They found both inhibitors failed consistently to protect the β-lactam antibiotic (ceftazidime) from attack by the β-lactamase enzyme. But when coupled with a different β-lactam antibiotic (aztreonam), the inhibitors worked very well - killing some of the most resistant bacteria the clinic had ever seen.

“Our bacteriology research has further demonstrated that β-lactamases are the real “Achilles heel” of antibiotic resistance in bacteria that kill thousands of people in the UK every year,” commented senior author Dr Matthew Alison from the University of Bristol.

“This is an exciting time for researchers studying β-lactamase inhibitors. At the risk of sounding like King Canute, it is the first time for a decade that there is some genuine positivity about our ability to turn back the rising tide of β-lactam antibiotic resistance.”

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.